Lab-Grown Blood Vessels by Biotech Humacyte Could Change Trauma Treatment.

Humacyte, a biotech company based in North Carolina, has developed lab-grown blood vessels using human cells to treat traumatic injuries and circulatory system problems. These blood vessels, which can replace damaged arteries, offer a new method for surgeons compared to synthetic grafts or using a patient's own blood vessels. The company has already implanted over 500 of these lab-grown blood vessels in humans and is seeking FDA approval for broader use. The technology has shown promising results in clinical trials, particularly in trauma patients, and could potentially revolutionize treatments for various medical conditions in the future. [Extracted from the article]